MELISSA JANOVITCH: Open Payments
NPI 1235375429 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 63 payments from 16 companies in 2025. Trend: 2023 $1,733 · 2024 $2,296 · 2025 $1,688
Food & beverage: $1,593Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $352 |
| Janssen Biotech, Inc. | 12 | $259 |
| Incyte Corporation | 5 | $224 |
| Regeneron Healthcare Solutions, Inc. | 6 | $139 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| LEO Pharma Inc. | 4 | $118 |
| Arcutis Biotherapeutics, Inc. | 5 | $102 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| GENZYME CORPORATION | 2 | $63 |
| Amgen Inc. | 3 | $49 |
Products named: TREMFYA, OPZELURA, SKYRIZI, RINVOQ, DUPIXENT, Zoryve, LIBTAYO, ILUMYA.
Industry payments across CA — which companies pay providers there.
